Skip to main content
CriticalFDAfda-F-0880-2018FIRE OR BURN

Life Change Fat Burner, 90 Gel Caps!, Burn Fat!, Remove fat from the liver! 1000mg; 2 capsules daily

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (fire or burn). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
552
Recall Date
February 23, 2018
Issuing Agency
Hazard
Fire Or Burn

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0880-2018.

Get The Tea is notifying customers that Life Change Fat Burners contain soy.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0880-2018.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Get The Tea or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0880-2018.

Get The Tea

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Get The Tea Recall FAQ

Get The Tea is the subject of a food safety report: Life Change Fat Burner, 90 Gel Caps!, Burn Fat!, Remove fat from the liver! 1000mg; 2 capsules daily. The notice was published on February 23, 2018 by the U.S. Food and Drug Administration (FDA). Approximately 552 units are potentially affected.